Patent · US Expired

Isothiourea derivatives of imadazo[2,1-b]Thiazoles and 5,6-dihydro derivatives thereof useful as CXCR4 chemokine receptor inhibitors

US7671078B2 · kind B2 · utility

0Cited by

7References

7Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Fraser Glickman · Basel, CH
Markus Streiff · Birsfelden, CH
Gebhard Thoma · Lörrach, DE
Hans-Gunter Zerwes · Lörrach, DE

Key dates

Filing date	Feb 25, 2005
Grant date	Mar 2, 2010
Priority date	—
Expiry date	Jan 25, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to isothiourea derivatives of formula I:wherein R1 is a residue of one of the following structures:where the variables are as defined in the claims of the invention, as well as processes for production of these compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.